Salmeterol/Fluticasone 50/500 mcg inhalation powder via Capsair
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Salmeterol/Fluticasone 50/500 mcg inhalation powder via Capsair, covering 2022-05-20 to 2022-05-20. Get the full timeline:
Most recent: Clinical Trial Update: Salmeterol/Fluticasone 50/500 mcg Inhalation Powder Via Capsair vs Seretide Diskus 500 mcg Inhalation Powder in Patients With COPD [Phase 4]